Advertisement

Aging Clinical and Experimental Research

, Volume 30, Issue 5, pp 413–418 | Cite as

Quality of life assessment in musculo-skeletal health

  • Charlotte BeaudartEmail author
  • Emmanuel Biver
  • Olivier Bruyère
  • Cyrus Cooper
  • Nasser Al-Daghri
  • Jean-Yves Reginster
  • René Rizzoli
Review

Abstract

Musculoskeletal disorders affect morbidity, quality of life and mortality, and represent an increasing economic and societal burden in the context of population aging and increased life expectancy. Improvement of quality of life should be one of the priorities of any interventions to prevent and treat musculoskeletal disorders in the ageing population. Two main approaches, namely generic and disease-specific instruments, can be applied to measure health-related quality of life. Among the generic tools available in scientific literature, the short form 36 questionnaire (SF-36) and the Euroqol five item questionnaire (EQ-5D) are two of the most popular questionnaires used to quantify the health related quality of life in people with musculoskeletal disorders. However, because generic tools may not always be able to detect subtle effects of a specific condition on quality of life, a specific tool is highly valuable. Specific tools improve the ability to clinically characterize quality of life in subjects with a specific musculoskeletal disorder, as well as the capacity to assess changes over time in the QoL of these subjects. The recent development of specific tools should help to validate preventive and therapeutic interventions in this field.

Keywords

Quality of life Musculo-skeletal health Sarcopenia Osteoporosis Osteoarthritis Frailty 

Notes

Acknowledgements

We thank the Prince Mutaib Bin Abdullah Chair for Biomarkers of Osteoporosis and Deanship of Scientific Research, King Saud University for their support.

Compliance with ethical standards

Conflict of interest

Charlotte Beaudart, Olivier Bruyère and Jean-Yves Reginster are the shareholders of SarQoL® sprl. Others authors have no relevant competing interests to declare.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study informed consent is not required.

References

  1. 1.
    Hoy DG, Smith E, Cross M et al (2014) The global burden of musculoskeletal conditions for 2010: an overview of methods. Ann Rheum Dis 73:982–989CrossRefPubMedGoogle Scholar
  2. 2.
    Prince MJ, Wu F, Guo Y et al (2015) The burden of disease in older people and implications for health policy and practice. Lancet 385:549–562CrossRefPubMedGoogle Scholar
  3. 3.
    Chatterji S, Byles J, Cutler D et al (2015) Health, functioning, and disability in older adults–present status and future implications. Lancet 385:563–575CrossRefPubMedGoogle Scholar
  4. 4.
    March L, Smith EUR, Hoy DG et al (2014) Burden of disability due to musculoskeletal (MSK) disorders. Best Pract Res Clin Rheumatol 28:353–366CrossRefPubMedGoogle Scholar
  5. 5.
    Murray CJL, Barber RM, Foreman KJ et al (2015) Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet 386:2145–2191CrossRefPubMedGoogle Scholar
  6. 6.
    Beaudart C, Zaaria M, Pasleau F et al (2017) Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One Public Libr Sci 12:e0169548CrossRefGoogle Scholar
  7. 7.
    Cesari M, Landi F, Calvani R et al (2017) Rationale for a preliminary operational definition of physical frailty and sarcopenia in the SPRINTT trial. Aging Clin Exp Res 29:81–88CrossRefPubMedGoogle Scholar
  8. 8.
    Marzetti E, Calvani R, Tosato M et al (2017) Sarcopenia: an overview. Aging Clin Exp Res 29:11–17CrossRefPubMedGoogle Scholar
  9. 9.
    Cruz-Jentoft AJ, Kiesswetter E, Drey M et al (2017) Nutrition, frailty, and sarcopenia. Aging Clin Exp Res 29:43–48CrossRefPubMedGoogle Scholar
  10. 10.
    Bartley MM, Geda YE, Christianson TJH et al (2016) Frailty and mortality outcomes in cognitively normal older people: sex differences in a population-based study. J Am Geriatr Soc 64:132–137CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Dawson A, Dennison E (2016) Measuring the musculoskeletal aging phenotype. Maturitas 93:13–17CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet (London, England) 359:1761–1767CrossRefGoogle Scholar
  13. 13.
    Cross M, Smith E, Hoy D et al (2014) The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73:1323–1330CrossRefPubMedGoogle Scholar
  14. 14.
    Johnell O, Kanis J (2005) Epidemiology of osteoporotic fractures. Osteoporos Int 16:S3–S7CrossRefPubMedGoogle Scholar
  15. 15.
    Lippuner K, Johansson H, Kanis JA et al (2009) Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporos Int 20:1131–1140CrossRefPubMedGoogle Scholar
  16. 16.
    Hars M, Biver E, Chevalley T et al (2016) Low lean mass predicts incident fractures independently from FRAX: a prospective cohort study of recent retirees. J Bone Miner Res 31:2048–2056CrossRefPubMedGoogle Scholar
  17. 17.
    Scott D, Chandrasekara SD, Laslett LL et al (2016) Associations of sarcopenic obesity and dynapenic obesity with bone mineral density and incident fractures over 5–10 years in community-dwelling older adults. Calcif Tissue Int 99:30–42CrossRefPubMedGoogle Scholar
  18. 18.
    Bischoff-Ferrari HA, Orav JE, Kanis JA et al (2015) Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older. Osteoporos Int 26:2793–2802CrossRefPubMedGoogle Scholar
  19. 19.
    Beaudart C, Rizzoli R, Bruyère O et al (2014) Sarcopenia: burden and challenges for public health. Arch Public Health 72:45CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Xie F, Kovic B, Jin X et al (2016) Economic and humanistic burden of osteoarthritis: a systematic review of large sample studies. Pharmacoeconomics 34:1087–1100CrossRefPubMedGoogle Scholar
  21. 21.
    Abimanyi-Ochom J, Watts JJ, Borgström F et al (2015) Changes in quality of life associated with fragility fractures: Australian arm of the International Cost and Utility Related to Osteoporotic Fractures Study (AusICUROS). Osteoporos Int 26:1781–1790CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Tarride J-E, Burke N, Leslie WD et al (2016) Loss of health related quality of life following low-trauma fractures in the elderly. BMC Geriatr 16:84CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Al-Sari UA, Tobias J, Clark E (2016) Health-related quality of life in older people with osteoporotic vertebral fractures: a systematic review and meta-analysis. Osteoporos Int 27:2891–2900CrossRefPubMedGoogle Scholar
  24. 24.
    Yu W-Y, Hwang H-F, Hu M-H et al (2013) Effects of fall injury type and discharge placement on mortality, hospitalization, falls, and ADL changes among older people in Taiwan. Accid Anal Prev 50:887–894CrossRefPubMedGoogle Scholar
  25. 25.
    Dyer SM, Crotty M, Fairhall N et al (2016) A critical review of the long-term disability outcomes following hip fracture. BMC Geriatr 16:158CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Leslie WD, Lix LM, Finlayson GS et al (2013) Direct healthcare costs for 5 years post-fracture in Canada: a long-term population-based assessment. Osteoporos Int 24:1697–1705CrossRefPubMedGoogle Scholar
  27. 27.
    Leal J, Gray AM, Prieto-Alhambra D et al (2016) Impact of hip fracture on hospital care costs: a population-based study. Osteoporos Int 27:549–558CrossRefPubMedGoogle Scholar
  28. 28.
    Lippuner K, Golder M, Greiner R (2005) Epidemiology and direct medical costs of osteoporotic fractures in men and women in Switzerland. Osteoporos Int 16:S8–S17CrossRefPubMedGoogle Scholar
  29. 29.
    Svedbom A, Ivergård M, Hernlund E et al (2014) Epidemiology and economic burden of osteoporosis in Switzerland. Arch Osteoporos 9:187CrossRefPubMedGoogle Scholar
  30. 30.
    Morin S, Lix LM, Azimaee M et al (2012) Institutionalization following incident non-traumatic fractures in community-dwelling men and women. Osteoporos Int 23:2381–2386CrossRefPubMedGoogle Scholar
  31. 31.
    Gill TM, Murphy TE, Gahbauer EA et al (2013) Association of injurious falls with disability outcomes and nursing home admissions in community-living older persons. Am J Epidemiol 178:418–425CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Verlaan S, Aspray TJ, Bauer JM et al (2017) Nutritional status, body composition, and quality of life in community-dwelling sarcopenic and non-sarcopenic older adults: a case-control study. Clin Nutr 36:267–274CrossRefPubMedGoogle Scholar
  33. 33.
    Filippin LI, Teixeira VN de O, da Silva MPM, Miraglia F, da Silva FS (2015) Sarcopenia: a predictor of mortality and the need for early diagnosis and intervention. Aging Clin Exp Res 27:249–254CrossRefPubMedGoogle Scholar
  34. 34.
    Cawthon PM, Lui L-Y, McCulloch CE et al (2016) Sarcopenia and health care utilization in older women. J Gerontol A Biol Sci Med Sci 2016:glw118Google Scholar
  35. 35.
    Morin S, Lix LM, Azimaee M et al (2011) Mortality rates after incident non-traumatic fractures in older men and women. Osteoporos Int 22:2439–2448CrossRefPubMedGoogle Scholar
  36. 36.
    Bliuc D, Nguyen ND, Milch VE et al (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513–521CrossRefPubMedGoogle Scholar
  37. 37.
    von Friesendorff M, McGuigan FE, Wizert A et al (2016) Hip fracture, mortality risk, and cause of death over two decades. Osteoporos Int 27:2945–2953CrossRefGoogle Scholar
  38. 38.
    Kluzek S, Sanchez-Santos MT, Leyland KM et al (2016) Painful knee but not hand osteoarthritis is an independent predictor of mortality over 23 years follow-up of a population-based cohort of middle-aged women. Ann Rheum Dis 75:1749–1756CrossRefPubMedGoogle Scholar
  39. 39.
    De Buyser SL, Petrovic M, Taes YE et al (2016) Validation of the FNIH sarcopenia criteria and SOF frailty index as predictors of long-term mortality in ambulatory older men. Age Ageing 45:602–608CrossRefPubMedGoogle Scholar
  40. 40.
    Ensrud KE, Lui L-Y, Paudel ML et al (2016) Effects of mobility and cognition on risk of mortality in women in late life: a prospective study. J Gerontol A Biol Sci Med Sci 71:759–765CrossRefPubMedGoogle Scholar
  41. 41.
    Briggs AM, Cross MJ, Hoy DG et al Musculoskeletal health conditions represent a global threat to healthy aging: a report for the 2015 World Health Organization World Report on Ageing and HealthGoogle Scholar
  42. 42.
    Revicki DA, Osoba D, Fairclough D et al (2000) Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 9:887–900CrossRefPubMedGoogle Scholar
  43. 43.
    Ul-Haq Z, Mackay DF, Pell JP et al (2014) Association between physical and mental health-related quality of life and adverse outcomes; a retrospective cohort study of 5,272 Scottish adults. BMC Public Health 14:1197CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Trombetti A, Reid KF, Hars M et al (2016) Age-associated declines in muscle mass, strength, power, and physical performance: impact on fear of falling and quality of life. Osteoporos Int 27:463–471CrossRefPubMedGoogle Scholar
  45. 45.
    Nglazi MD, West SJ, Dave JA et al (2014) Quality of life in individuals living with HIV/AIDS attending a public sector antiretroviral service in Cape Town, South Africa. BMC Public Health 14:676CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Zhou J, Ru X, Hearst N et al (2014) Individual and household-level predictors of health related quality of life among middle-aged people in rural Mid-east China: a cross-sectional study. BMC Public Health 14:660CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Guyatt GH, Bombardier C, Tugwell PX (1986) Measuring disease-specific quality of life in clinical trials. CMAJ 134:889–895PubMedPubMedCentralGoogle Scholar
  48. 48.
    Rizzoli R, Reginster JY, Arnal JF et al (2013) Quality of life in sarcopenia and frailty. Calcif Tissue Int 93:101–120CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Syddall HE, Martin HJ, Harwood RH et al (2009) The SF-36: a simple, effective measure of mobility-disability for epidemiological studies. J Nutr Health Aging 13:57–62CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483CrossRefPubMedGoogle Scholar
  51. 51.
    Rabin R, de Charro F (2001) EQ-5D: a measure of health status from the EuroQol Group. Ann Med 33:337–343CrossRefPubMedGoogle Scholar
  52. 52.
    Ahrens C, Schiltenwolf M, Wang H (2010) Health-related quality of life (SF-36) in chronic low back pain and comorbid depression. Schmerz 24:251–256CrossRefPubMedGoogle Scholar
  53. 53.
    Adorno MLGR, Brasil-Neto JP (2013) Assessment of the quality of life through the SF-36 questionnaire in patients with chronic nonspecific low back pain. Acta Ortop Bras Braz Soc Orthop Traumatol 21:202–207CrossRefGoogle Scholar
  54. 54.
    Veresciagina K, Ambrozaitis KV, Spakauskas B (2007) Health-related quality-of-life assessment in patients with low back pain using SF-36 questionnaire. Medicina (B Aires) 43:607–613Google Scholar
  55. 55.
    Talamo J, Frater A, Gallivan S et al (1997) Use of the short form 36 (SF36) for health status measurement in rheumatoid arthritis. Rheumatology 36:463–469CrossRefGoogle Scholar
  56. 56.
    Kosinski M, Keller SD, Ware JE et al (1999) The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: relative validity of scales in relation to clinical measures of arthritis severity. Med Care 37:MS23–MS39PubMedGoogle Scholar
  57. 57.
    Hill CL, Parsons J, Taylor A et al (1999) Health related quality of life in a population sample with arthritis. J Rheumatol 26:2029–2035PubMedGoogle Scholar
  58. 58.
    Angst F, Aeschlimann A, Steiner W et al (2001) Responsiveness of the WOMAC osteoarthritis index as compared with the SF-36 in patients with osteoarthritis of the legs undergoing a comprehensive rehabilitation intervention. Ann Rheum Dis BMJ Group 60:834–840Google Scholar
  59. 59.
    Matcham F, Scott IC, Rayner L et al (2014) The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: A systematic review and meta-analysis. Semin Arthritis Rheum 44:123–130CrossRefPubMedGoogle Scholar
  60. 60.
    Zanoli G, Jönsson B, Strömqvist B (2006) SF-36 scores in degenerative lumbar spine disorders: analysis of prospective data from 451 patients. Acta Orthop 77:298–306CrossRefPubMedGoogle Scholar
  61. 61.
    Guilfoyle MR, Seeley H, Laing RJ (2009) The Short Form 36 health survey in spine disease–validation against condition-specific measures. Br J Neurosurg 23:401–405CrossRefPubMedGoogle Scholar
  62. 62.
    Neumann L, Berzak A, Buskila D (2000) Measuring health status in Israeli patients with fibromyalgia syndrome and widespread pain and healthy individuals: utility of the short form 36-item health survey (SF-36). Semin Arthritis Rheum 29:400–408CrossRefPubMedGoogle Scholar
  63. 63.
    Salaffi F, Sarzi-Puttini P, Girolimetti R et al (2009) Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey. Clin Exp Rheumatol 27:S67–S74PubMedGoogle Scholar
  64. 64.
    Beaudart C, Reginster JY, Petermans J et al (2015) Quality of life and physical components linked to sarcopenia: the SarcoPhAge study. Exp Gerontol 69:103–110CrossRefPubMedGoogle Scholar
  65. 65.
    Yadav A, Chang Y-H, Carpenter S et al (2015) Relationship between sarcopenia, six-minute walk distance and health-related quality of life in liver transplant candidates. Clin Transplant 29:134–141CrossRefPubMedGoogle Scholar
  66. 66.
    Silva Neto LS, Karnikowiski MG, Tavares AB et al (2012) Association between sarcopenia, sarcopenic obesity, muscle strength and quality of life variables in elderly women. Rev Bras Fisioter 16:360–367CrossRefPubMedGoogle Scholar
  67. 67.
    Johnsen LG, Hellum C, Nygaard ØP et al (2013) Comparison of the SF6D, the EQ5D, and the oswestry disability index in patients with chronic low back pain and degenerative disc disease. BMC Musculoskelet Disord 14:148CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Whynes DK, McCahon RA, Ravenscroft A et al (2013) Responsiveness of the EQ-5D health-related quality-of-life instrument in assessing low back pain. Value Health 16:124–132CrossRefPubMedGoogle Scholar
  69. 69.
    Fransen M, Edmonds J (1999) Reliability and validity of the EuroQol in patients with osteoarthritis of the knee. Rheumatology 38:807–813CrossRefPubMedGoogle Scholar
  70. 70.
    Hernandez Alava M, Wailoo A, Wolfe F et al (2013) The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis. Rheumatology 52:944–950CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Hurst NP, Kind P, Ruta D et al (1997) Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Rheumatology 36:551–559CrossRefGoogle Scholar
  72. 72.
    Go SW, Cha YH, Lee JA et al (2013) Association between sarcopenia, bone density, and health-related quality of life in Korean Men. Korean J Fam Med 34:281–288CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Wolfe F, Hawley DJ (1997) Measurement of the quality of life in rheumatic disorders using the EuroQol. Br J Rheumatol 36:786–793CrossRefPubMedGoogle Scholar
  74. 74.
    Picavet HSJ, Hoeymans N (2004) Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study. Ann Rheum Dis BMJ Group 63:723–729CrossRefGoogle Scholar
  75. 75.
    Ware JE Jr (1996) The SF-36 Health Survey. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials, 2nd edn. Lippincott-Raven, Philadalphia, pp 337–344Google Scholar
  76. 76.
    Lips P, Cooper C, Agnusdei D et al (1999) Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int 10:150–160CrossRefPubMedGoogle Scholar
  77. 77.
    Marquis P, Cialdella P, De la Loge C (2001) Development and validation of a specific quality of life module in post-menopausal women with osteoporosis: the QUALIOST. Qual Life Res 10:555–566CrossRefPubMedGoogle Scholar
  78. 78.
    Randell AG, Bhalerao N, Nguyen TV et al (1998) Quality of life in osteoporosis: reliability, consistency, and validity of the Osteoporosis Assessment Questionnaire. J Rheumatol 25:1171–1179PubMedGoogle Scholar
  79. 79.
    Measuring quality of life in women with osteoporosis (1997) Osteoporosis Quality of Life Study Group. Osteoporos Int 7:478–487CrossRefGoogle Scholar
  80. 80.
    Helmes E, Hodsman A, Lazowski D et al (1995) A questionnaire to evaluate disability in osteoporotic patients with vertebral compression fractures. J Gerontol A Biol Sci Med Sci 50:M91–M98CrossRefPubMedGoogle Scholar
  81. 81.
    Lydick E, Zimmerman SI, Yawn B et al (1997) Development and validation of a discriminative quality of life questionnaire for osteoporosis (the OPTQoL). J Bone Miner Res 12:456–463CrossRefPubMedGoogle Scholar
  82. 82.
    Tijhuis GJ, Jong Z de, Zwinderman AH et al (2001) The validity of the rheumatoid arthritis quality of life (RAQoL) questionnaire. Rheumatology 40:1112–1119CrossRefPubMedGoogle Scholar
  83. 83.
    Rat A-C, Coste J, Pouchot J et al (2005) OAKHQOL: a new instrument to measure quality of life in knee and hip osteoarthritis. J Clin Epidemiol 58:47–55CrossRefPubMedGoogle Scholar
  84. 84.
    McKenna SP, Doward LC, Whalley D et al (2004) Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis BMJ Group 63:162–169CrossRefGoogle Scholar
  85. 85.
    Beaudart C, Biver E, Reginster J-Y et al (2015) Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL. Age Ageing 44:960–966CrossRefPubMedPubMedCentralGoogle Scholar
  86. 86.
    Bennett RM, Friend R, Jones KD et al (2009) The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther 11:R120CrossRefPubMedPubMedCentralGoogle Scholar
  87. 87.
    Reginster J-Y, Cooper C, Rizzoli R et al (2016) Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia. Aging Clin Exp Res 28:47–58CrossRefPubMedGoogle Scholar
  88. 88.
    Landi F, Cesari M, Calvani R et al (2017) The sarcopenia and physical fRailty IN older people: multi-componenT Treatment strategies? (SPRINTT) randomized controlled trial: design and methods. Aging Clin Exp Res 29:89–100CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of Public Health, Epidemiology and Health EconomicsUniversity of Liège, Quartier HôpitalLiègeBelgium
  2. 2.Division of Bone Diseases, Faculty of MedicineGeneva University HospitalsGeneva 14Switzerland
  3. 3.MRC Lifecourse Epidemiology UnitUniversity of SouthamptonSouthamptonUK
  4. 4.NIHR Musculoskeletal Biomedical Research UnitUniversity of OxfordOxfordUK
  5. 5.Prince Mutaib Chair for Biomarkers of Osteoporosis, Biochemistry Department, College of ScienceKing Saud UniversityRiyadhSaudi Arabia
  6. 6.Director of the Bone, Cartilage and Muscle Metabolism Unit and Chair of the Department of Public Health SciencesCHU LiègeLiègeBelgium

Personalised recommendations